Effective treatment of a child with adenoidal hypertrophy and severe asthma by omalizumab: a case report

Sui, HJ; Zhang, HS; Ding, W; Zhao, ZT; Mo, JL; Yuan, JX; Ye, LP

Ye, LP (通讯作者),Peking Univ First Hosp, Dept Pediat, 1 Xian Men St, Beijing 100034, Peoples R China.;Ye, LP (通讯作者),Peking Univ First Hosp, Ctr Diag & Treatment United Airways Dis, Dept Pediat, Beijing, Peoples R China.;Ye, LP (通讯作者),Peking Univ First Hosp, Ctr Diag & Treatment United Airways Dis, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.;Ye, LP (通讯作者),Peking Univ First Hosp, Ctr Diag & Treatment United Airways Dis, Dept Dermatol, Beijing, Peoples R China.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022; 18 (1):

Abstract

Background Childhood adenoid hypertrophy (AH) is common and is often associated with allergic asthma, resulting in complications like obstructive slee......

Full Text Link